- Home
- LFST vs CLDX Comparison
LFST vs CLDX Comparison
Compare LFST & CLDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LFST | CLDX |
|---|---|---|
| Founded | 2015 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Nursing Services | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 2.1B |
| IPO Year | 2021 | 1995 |
Fundamental Metrics
Financial Performance| Metric | LFST | CLDX |
|---|---|---|
| Price | $6.94 | $34.53 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 10 |
| Target Price | $9.83 | ★ $44.50 |
| AVG Volume (30 Days) | ★ 1.5M | 1.2M |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,424,285,000.00 | $12,743,000.00 |
| Revenue This Year | $17.18 | $111.39 |
| Revenue Next Year | $14.02 | $235.85 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | 13.85 | ★ 87.78 |
| 52 Week Low | $3.74 | $17.87 |
| 52 Week High | $8.09 | $35.29 |
Technical Indicators
Market Signals| Indicator | LFST | CLDX |
|---|---|---|
| Relative Strength Index (RSI) | 62.65 | 65.05 |
| Support Level | $6.75 | $24.70 |
| Resistance Level | $7.33 | $34.52 |
| Average True Range (ATR) | 0.17 | 1.46 |
| MACD | 0.08 | 0.16 |
| Stochastic Oscillator | 93.51 | 81.67 |
Price Performance
Historical ComparisonAbout LFST LifeStance Health Group Inc.
LifeStance Health Group Inc is a mental healthcare company that operates as a provider of outpatient mental health services, spanning psychiatric evaluations and treatment, psychological and neuropsychological testing, and individual, family, and group therapy. It treats a broad range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder, using evidence-based approaches to ensure effective treatment. The group has a single operating and reportable segment of mental health services.
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical firm focused on mast cell biology and the development of therapeutic antibodies. Its pipeline includes monoclonal and bispecific antibodies aimed at treating severe inflammatory, allergic, autoimmune, and other mast cell-mediated diseases. The company operates in a single operating and reportable segment in the business of development, manufacturing and commercialization of novel therapeutics for human health care.